 | 58E | Name: | (5aS,6S,9aS)-7-hydroxy-2,6,9a-trimethyl-3-(pyridin-3-yl)-4,5,5a,6,9,9a-hexahydro-2H-benzo[g]indazole-8-carbonitrile | Formula: | C20 H22 N4 O | SMILES: | OC=4C(C)C3CCc1c(nn(c1c2cccnc2)C)C3(C)CC=4C#N | InChi: | InChI=1S/C20H22N4O/c1-12-16-7-6-15-17(13-5-4-8-22-11-13)24(3)23-19(15)20(16,2)9-14(10-21)18(12)25/h4-5,8,11-12,16,25H,6-7,9H2,1-3H3/t12-,16-,20-/m0/s1 | Definition date: | 2015-08-20 | Last modified: | 2024-09-27 | Release date: | 2016-08-10 | Identifier: | (5aS,6S,9aS)-7-hydroxy-2,6,9a-trimethyl-3-(pyridin-3-yl)-4,5,5a,6,9,9a-hexahydro-2H-benzo[g]indazole-8-carbonitrile |
|
 | TM8 | Name: | Nalpha-[(benzyloxy)carbonyl]-N-[(2S)-1-phenyl-4-(phenylsulfonyl)butan-2-yl]-L-phenylalaninamide | Formula: | C33 H34 N2 O5 S | SMILES: | N(C(OCc1ccccc1)=O)C(Cc2ccccc2)C(=O)NC(CCS(c3ccccc3)(=O)=O)Cc4ccccc4 | InChi: | InChI=1S/C33H34N2O5S/c36-32(31(24-27-15-7-2-8-16-27)35-33(37)40-25-28-17-9-3-10-18-28)34-29(23-26-13-5-1-6-14-26)21-22-41(38,39)30-19-11-4-12-20-30/h1-20,29,31H,21-25H2,(H,34,36)(H,35,37)/t29-,31+/m1/s1 | Definition date: | 2019-11-07 | Last modified: | 2024-09-27 | Release date: | 2020-11-25 | Identifier: | Nalpha-[(benzyloxy)carbonyl]-N-[(2S)-1-phenyl-4-(phenylsulfonyl)butan-2-yl]-L-phenylalaninamide |
|
 | TMD | Name: | (6,7-DIHYDRO)4-[(E)-BUTENYL]-4,N-DIMETHYL-THREONINE | Formula: | C10 H21 N O3 | SMILES: | O=C(O)C(NC)C(O)C(CCCC)C | InChi: | InChI=1S/C10H21NO3/c1-4-5-6-7(2)9(12)8(11-3)10(13)14/h7-9,11-12H,4-6H2,1-3H3,(H,13,14)/t7-,8+,9-/m1/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | 4-butyl-2,4,5-trideoxy-2-(methylamino)-L-xylonic acid |
|
 | TME | Name: | PROPANE | Formula: | C3 H8 | SMILES: | CCC | InChi: | InChI=1S/C3H8/c1-3-2/h3H2,1-2H3 | Definition date: | 2001-01-24 | Last modified: | 2024-09-27 | Identifier: | propane |
|
 | TMM | Name: | 1,3,5-BENZENETRICARBOXYLIC ACID | Formula: | C9 H6 O6 | SMILES: | O=C(O)c1cc(cc(C(=O)O)c1)C(=O)O | InChi: | InChI=1S/C9H6O6/c10-7(11)4-1-5(8(12)13)3-6(2-4)9(14)15/h1-3H,(H,10,11)(H,12,13)(H,14,15) | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | benzene-1,3,5-tricarboxylic acid |
|
 | 59A | Name: | N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCINE | Formula: | C12 H19 N O6 | SMILES: | O=C(NC(C(=O)O)C(C)CC)C1OC1C(=O)OCC | InChi: | InChI=1S/C12H19NO6/c1-4-6(3)7(11(15)16)13-10(14)8-9(19-8)12(17)18-5-2/h6-9H,4-5H2,1-3H3,(H,13,14)(H,15,16)/t6-,7-,8-,9-/m0/s1 | Synonyms: | CA059 | Definition date: | 2006-01-04 | Last modified: | 2024-09-27 | Identifier: | N-{[(2S,3S)-3-(ethoxycarbonyl)oxiran-2-yl]carbonyl}-L-isoleucine |
|
 | TN4 | Name: | (1R,2S,3S,4R)-4-hydroxy-2-methoxy-4-methyl-3-[(2R,3R)-2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]cyclohexyl
(chloroacetyl)carbamate | Formula: | C19 H30 Cl N O6 | SMILES: | ClCC(=O)NC(=O)OC2CCC(O)(C(C1(OC1C/C=C(/C)C)C)C2OC)C | InChi: | InChI=1S/C19H30ClNO6/c1-11(2)6-7-13-19(4,27-13)16-15(25-5)12(8-9-18(16,3)24)26-17(23)21-14(22)10-20/h6,12-13,15-16,24H,7-10H2,1-5H3,(H,21,22,23)/t12-,13-,15-,16+,18-,19+/m1/s1 | Synonyms: | TNP-470 (Open form) | Definition date: | 2003-04-24 | Last modified: | 2024-09-27 | Identifier: | (1R,2S,3S,4R)-4-hydroxy-2-methoxy-4-methyl-3-[(2R,3R)-2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]cyclohexyl (chloroacetyl)carbamate |
|
 | 59F | Name: | (2R,4R,5R)-2-[(1R)-1-{[(2R)-2-{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}-2-(4-hydroxyphenyl)acetyl]amino}-2-oxoethyl]-5-methyl-1,3-thiazinane-4-carboxylic acid | Formula: | C23 H29 N5 O8 S | SMILES: | C(N1C(C(=O)N(CC1)CC)=O)(NC(C(=O)NC(C2SCC(C(N2)C(O)=O)C)C=O)c3ccc(O)cc3)=O | InChi: | InChI=1S/C23H29N5O8S/c1-3-27-8-9-28(21(33)20(27)32)23(36)26-17(13-4-6-14(30)7-5-13)18(31)24-15(10-29)19-25-16(22(34)35)12(2)11-37-19/h4-7,10,12,15-17,19,25,30H,3,8-9,11H2,1-2H3,(H,24,31)(H,26,36)(H,34,35)/t12-,15+,16+,17+,19+/m0/s1 | Definition date: | 2015-08-27 | Last modified: | 2024-09-27 | Release date: | 2016-01-13 | Identifier: | (2R,4R,5R)-2-[(1R)-1-{[(2R)-2-{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}-2-(4-hydroxyphenyl)acetyl]amino}-2-oxoethyl]-5-methyl-1,3-thiazinane-4-carboxylic acid |
|
 | TN6 | Name: | diethylphosphoramidic acid | Formula: | C4 H12 N O3 P | SMILES: | O=P(O)(O)N(CC)CC | InChi: | InChI=1S/C4H12NO3P/c1-3-5(4-2)9(6,7)8/h3-4H2,1-2H3,(H2,6,7,8) | Definition date: | 2009-05-11 | Last modified: | 2024-09-27 | Identifier: | diethylphosphoramidic acid |
|
 | TN7 | Name: | ethyl hydrogen ethylamidophosphate | Formula: | C4 H12 N O3 P | SMILES: | O=P(O)(OCC)NCC | InChi: | InChI=1S/C4H12NO3P/c1-3-5-9(6,7)8-4-2/h3-4H2,1-2H3,(H2,5,6,7) | Definition date: | 2009-05-12 | Last modified: | 2024-09-27 | Identifier: | ethyl hydrogen ethylamidophosphate |
|
 | 59I | Name: | (2R,3R)-3-methyl-4-(2-oxidanylidene-2-propan-2-yloxy-ethyl)sulfanyl-2-[(2R)-3-oxidanyl-1-oxidanylidene-butan-2-yl]-2,3-dihydro-1H-pyrrole-5-carboxylic acid | Formula: | C15 H23 N O6 S | SMILES: | CC(C)OC(=O)CSC1=C(N[CH]([CH]1C)[CH](C=O)C(C)O)C(O)=O | InChi: | InChI=1S/C15H23NO6S/c1-7(2)22-11(19)6-23-14-8(3)12(10(5-17)9(4)18)16-13(14)15(20)21/h5,7-10,12,16,18H,6H2,1-4H3,(H,20,21)/t8-,9?,10?,12+/m1/s1 | Definition date: | 2021-08-12 | Last modified: | 2024-09-27 | Release date: | 2022-05-11 | Identifier: | (2~{R},3~{R})-3-methyl-4-(2-oxidanylidene-2-propan-2-yloxy-ethyl)sulfanyl-2-[(2~{R})-3-oxidanyl-1-oxidanylidene-butan-2-yl]-2,3-dihydro-1~{H}-pyrrole-5-carboxylic acid |
|
 | TNI | Name: | 5-bromo-3-[(3-bromo-4-chlorophenyl)methoxy]pyridine-2-carbaldehyde | Formula: | C13 H8 Br2 Cl N O2 | SMILES: | O=Cc1ncc(Br)cc1OCc1ccc(Cl)c(Br)c1 | InChi: | InChI=1S/C13H8Br2ClNO2/c14-9-4-13(12(6-18)17-5-9)19-7-8-1-2-11(16)10(15)3-8/h1-6H,7H2 | Definition date: | 2022-07-27 | Last modified: | 2024-09-27 | Release date: | 2023-06-28 | Identifier: | 5-bromo-3-[(3-bromo-4-chlorophenyl)methoxy]pyridine-2-carbaldehyde |
|
 | TNQ | Name: | 6-[(carboxymethyl)amino]-7-hydroxy-L-tryptophan | Formula: | C13 H15 N3 O5 | SMILES: | NC(C(=O)O)Cc1cnc2c1ccc(c2O)NCC(=O)O | InChi: | InChI=1S/C13H15N3O5/c14-8(13(20)21)3-6-4-16-11-7(6)1-2-9(12(11)19)15-5-10(17)18/h1-2,4,8,15-16,19H,3,5,14H2,(H,17,18)(H,20,21)/t8-/m0/s1 | Definition date: | 2018-08-16 | Last modified: | 2024-09-27 | Release date: | 2019-01-16 | Identifier: | 6-[(carboxymethyl)amino]-7-hydroxy-L-tryptophan |
|
 | KB2 | Name: | (3S)-3-(4-{(1S)-1,2-dimethyl-1-[(quinolin-6-ylmethyl)amino]propyl}-1H-1,2,3-triazol-1-yl)heptan-2-one | Formula: | C24 H33 N5 O | SMILES: | O=C(C(n1nnc(c1)C(NCc3cc2cccnc2cc3)(C)C(C)C)CCCC)C | InChi: | InChI=1S/C24H33N5O/c1-6-7-10-22(18(4)30)29-16-23(27-28-29)24(5,17(2)3)26-15-19-11-12-21-20(14-19)9-8-13-25-21/h8-9,11-14,16-17,22,26H,6-7,10,15H2,1-5H3/t22-,24-/m0/s1 | Definition date: | 2009-09-09 | Last modified: | 2024-09-27 | Identifier: | (3S)-3-(4-{(2S)-3-methyl-2-[(quinolin-6-ylmethyl)amino]butan-2-yl}-1H-1,2,3-triazol-1-yl)heptan-2-one |
|
 | KBE | Name: | beta-lysine | Formula: | C6 H14 N2 O2 | SMILES: | NCCC[CH](N)CC(O)=O | InChi: | InChI=1S/C6H14N2O2/c7-3-1-2-5(8)4-6(9)10/h5H,1-4,7-8H2,(H,9,10)/t5-/m0/s1 | Synonyms: | (3S)-3,6-diaminohexanoic acid | Definition date: | 2010-02-05 | Last modified: | 2024-09-27 | Identifier: | (3S)-3,6-bis(azanyl)hexanoic acid |
|
 | 5AM | Name: | BENZYL {(1S)-5-AMINO-1-[(S)-HYDROXY(5-{[4-(4-PHENYLBUTANOYL)PIPERAZIN-1-YL]METHYL}-1,2,4-OXADIAZOL-3-YL)METHYL]PENTYL}CARBAMATE | Formula: | C31 H42 N6 O5 | SMILES: | O=C(N3CCN(Cc1nc(no1)C(O)C(NC(=O)OCc2ccccc2)CCCCN)CC3)CCCc4ccccc4 | InChi: | InChI=1S/C31H42N6O5/c32-17-8-7-15-26(33-31(40)41-23-25-12-5-2-6-13-25)29(39)30-34-27(42-35-30)22-36-18-20-37(21-19-36)28(38)16-9-14-24-10-3-1-4-11-24/h1-6,10-13,26,29,39H,7-9,14-23,32H2,(H,33,40)/t26-,29-/m0/s1 | Definition date: | 2006-03-30 | Last modified: | 2024-09-27 | Identifier: | benzyl {(1S)-5-amino-1-[(S)-hydroxy(5-{[4-(4-phenylbutanoyl)piperazin-1-yl]methyl}-1,2,4-oxadiazol-3-yl)methyl]pentyl}carbamate |
|
 | KBH | Name: | 4-(4-fluorophenyl)-3-fluorosulfonyl-benzoic acid | Formula: | C13 H8 F2 O4 S | SMILES: | OC(=O)c1ccc(c2ccc(F)cc2)c(c1)[S](F)(=O)=O | InChi: | InChI=1S/C13H8F2O4S/c14-10-4-1-8(2-5-10)11-6-3-9(13(16)17)7-12(11)20(15,18)19/h1-7H,(H,16,17) | Definition date: | 2019-05-09 | Last modified: | 2024-09-27 | Release date: | 2019-10-02 | Identifier: | 4-(4-fluorophenyl)-3-fluorosulfonyl-benzoic acid |
|
 | KBO | Name: | 2-ethyl-2-methanoyl-~{N}-[3-[[4-(quinolin-8-ylmethyl)piperazin-1-yl]methyl]phenyl]butanamide | Formula: | C28 H34 N4 O2 | SMILES: | CCC(CC)(C=O)C(=O)Nc1cccc(CN2CCN(CC2)Cc3cccc4cccnc34)c1 | InChi: | InChI=1S/C28H34N4O2/c1-3-28(4-2,21-33)27(34)30-25-12-5-8-22(18-25)19-31-14-16-32(17-15-31)20-24-10-6-9-23-11-7-13-29-26(23)24/h5-13,18,21H,3-4,14-17,19-20H2,1-2H3,(H,30,34) | Definition date: | 2022-05-23 | Last modified: | 2024-09-27 | Release date: | 2022-09-28 | Identifier: | 2-ethyl-2-methanoyl-~{N}-[3-[[4-(quinolin-8-ylmethyl)piperazin-1-yl]methyl]phenyl]butanamide |
|
 | 5BF | Name: | (11S)-4,9-dioxo-N-[(2S)-1-oxo-3-phenylpropan-2-yl]-17,22-dioxa-10,30-diazatetracyclo[21.2.2.2~13,16~.1~5,8~]triaconta-1(25),5,7,13,15,23,26,28-octaene-11-carboxamide | Formula: | C36 H37 N3 O6 | SMILES: | O=CC(NC(=O)C3NC(=O)c1ccc(n1)C(=O)CCc4ccc(OCCCCOc2ccc(cc2)C3)cc4)Cc5ccccc5 | InChi: | InChI=1S/C36H37N3O6/c40-24-28(22-26-6-2-1-3-7-26)37-36(43)33-23-27-10-15-30(16-11-27)45-21-5-4-20-44-29-13-8-25(9-14-29)12-19-34(41)31-17-18-32(38-31)35(42)39-33/h1-3,6-11,13-18,24,28,33,38H,4-5,12,19-23H2,(H,37,43)(H,39,42)/t28-,33-/m0/s1 | Definition date: | 2014-04-15 | Last modified: | 2024-09-27 | Release date: | 2014-07-23 | Identifier: | (11S)-4,9-dioxo-N-[(2S)-1-oxo-3-phenylpropan-2-yl]-17,22-dioxa-10,30-diazatetracyclo[21.2.2.2~13,16~.1~5,8~]triaconta-1(25),5,7,13,15,23,26,28-octaene-11-carboxamide |
|
 | KCJ | Name: | 3-(1,3-thiazol-4-yl)-L-alanine | Formula: | C6 H8 N2 O2 S | SMILES: | c1scnc1CC(C(O)=O)N | InChi: | InChI=1S/C6H8N2O2S/c7-5(6(9)10)1-4-2-11-3-8-4/h2-3,5H,1,7H2,(H,9,10)/t5-/m0/s1 | Definition date: | 2018-11-20 | Last modified: | 2024-09-27 | Release date: | 2019-10-02 | Identifier: | 3-(1,3-thiazol-4-yl)-L-alanine |
|
 | KCM | Name: | N-[(4S,5S)-4-amino-5-(1,3-benzothiazol-2-yl)-5-hydroxypentyl]guanidine | Formula: | C13 H19 N5 O S | SMILES: | C(CCCNC(N)=N)(N)C(c1sc2c(n1)cccc2)O | InChi: | InChI=1S/C13H19N5OS/c14-8(4-3-7-17-13(15)16)11(19)12-18-9-5-1-2-6-10(9)20-12/h1-2,5-6,8,11,19H,3-4,7,14H2,(H4,15,16,17)/t8-,11-/m0/s1 | Definition date: | 2018-11-20 | Last modified: | 2024-09-27 | Release date: | 2019-10-02 | Identifier: | N-[(4S,5S)-4-amino-5-(1,3-benzothiazol-2-yl)-5-hydroxypentyl]guanidine |
|
 | KCP | Name: | 2-[CARBOXY-(2-THIOPHEN-2-YL-ACETYLAMINO)-METHYL]-5-METHYL-3,6-DIHYDRO-2H-[1,3]THIAZINE-4-CARBOXYLIC ACID | Formula: | C14 H16 N2 O5 S2 | SMILES: | O=C(O)C(NC(=O)Cc1sccc1)C2SCC(=C(N2)C(=O)O)C | InChi: | InChI=1S/C14H16N2O5S2/c1-7-6-23-12(16-10(7)13(18)19)11(14(20)21)15-9(17)5-8-3-2-4-22-8/h2-4,11-12,16H,5-6H2,1H3,(H,15,17)(H,18,19)(H,20,21)/t11-,12-/m0/s1 | Synonyms: | HYDROLYZED CEPHALOTHIN | Definition date: | 2002-02-07 | Last modified: | 2024-09-27 | Identifier: | (2S)-2-{(R)-carboxy[(thiophen-2-ylacetyl)amino]methyl}-5-methyl-3,6-dihydro-2H-1,3-thiazine-4-carboxylic acid |
|
 | KCQ | Name: | (3S)-3-[(2S)-2-AMINO-3-OXOBUTYL]PYRROLIDIN-2-ONE | Formula: | C8 H14 N2 O2 | SMILES: | O=C1NCCC1CC(N)C(=O)C | InChi: | InChI=1S/C8H14N2O2/c1-5(11)7(9)4-6-2-3-10-8(6)12/h6-7H,2-4,9H2,1H3,(H,10,12)/t6-,7-/m0/s1 | Definition date: | 2007-06-07 | Last modified: | 2024-09-27 | Identifier: | (3S)-3-[(2S)-2-amino-3-oxobutyl]pyrrolidin-2-one |
|
 | KCR | Name: | N-6-crotonyl-L-lysine | Formula: | C10 H18 N2 O3 | SMILES: | NC(C(O)=O)CCCCNC(=O)[C@H]=[C@H]C | InChi: | InChI=1S/C10H18N2O3/c1-2-5-9(13)12-7-4-3-6-8(11)10(14)15/h2,5,8H,3-4,6-7,11H2,1H3,(H,12,13)(H,14,15)/b5-2+/t8-/m0/s1 | Definition date: | 2015-03-26 | Last modified: | 2024-09-27 | Release date: | 2015-09-16 | Identifier: | N~6~-[(2E)-but-2-enoyl]-L-lysine |
|
 | 5BV | Name: | (2R,3R)-3-(glycyloxy)-2-methylnonanoic acid | Formula: | C12 H23 N O4 | SMILES: | O=C(OC(C(C)C(=O)O)CCCCCC)CN | InChi: | InChI=1S/C12H23NO4/c1-3-4-5-6-7-10(9(2)12(15)16)17-11(14)8-13/h9-10H,3-8,13H2,1-2H3,(H,15,16)/t9-,10-/m1/s1 | Definition date: | 2015-09-03 | Last modified: | 2024-09-27 | Release date: | 2016-03-02 | Identifier: | (2R,3R)-3-(glycyloxy)-2-methylnonanoic acid |
|